Skip to main content
NCBI home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1996 Aug;80(8):681–682. doi: 10.1136/bjo.80.8.681

Prevention of postoperative infection: limits and possibilities.

S D Jaanus
PMCID: PMC505579  PMID: 8949707

Full text

PDF
681

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barza M., Doft B., Lynch E. Ocular penetration of ceftriaxone, ceftazidime, and vancomycin after subconjunctival injection in humans. Arch Ophthalmol. 1993 Apr;111(4):492–494. doi: 10.1001/archopht.1993.01090040084037. [DOI] [PubMed] [Google Scholar]
  2. Barza M., Kane A., Baum J. Ocular penetration of subconjunctival oxacillin, methicillin, and cefazolin in rabbits with staphylococcal endophthalmitis. J Infect Dis. 1982 Jun;145(6):899–903. doi: 10.1093/infdis/145.6.899. [DOI] [PubMed] [Google Scholar]
  3. Bohigian G. M., Olk R. J. Factors associated with a poor visual result in endophthalmitis. Am J Ophthalmol. 1986 Mar 15;101(3):332–341. doi: 10.1016/0002-9394(86)90829-9. [DOI] [PubMed] [Google Scholar]
  4. Campochiaro P. A., Conway B. P. Aminoglycoside toxicity--a survey of retinal specialists. Implications for ocular use. Arch Ophthalmol. 1991 Jul;109(7):946–950. doi: 10.1001/archopht.1991.01080070058035. [DOI] [PubMed] [Google Scholar]
  5. Campochiaro P. A., Lim J. I. Aminoglycoside toxicity in the treatment of endophthalmitis. The Aminoglycoside Toxicity Study Group. Arch Ophthalmol. 1994 Jan;112(1):48–53. doi: 10.1001/archopht.1994.01090130058017. [DOI] [PubMed] [Google Scholar]
  6. Doft B. H. The endophthalmitis vitrectomy study. Arch Ophthalmol. 1991 Apr;109(4):487–489. doi: 10.1001/archopht.1991.01080040055025. [DOI] [PubMed] [Google Scholar]
  7. Green K., Chapman J., Cheeks L. Ocular toxicity of subconjunctival gentamicin. Lens Eye Toxic Res. 1992;9(3-4):439–446. [PubMed] [Google Scholar]
  8. Irvine W. D., Flynn H. W., Jr, Miller D., Pflugfelder S. C. Endophthalmitis caused by gram-negative organisms. Arch Ophthalmol. 1992 Oct;110(10):1450–1454. doi: 10.1001/archopht.1992.01080220112031. [DOI] [PubMed] [Google Scholar]
  9. Jenkins C. D., McDonnell P. J., Spalton D. J. Randomised single blind trial to compare the toxicity of subconjunctival gentamicin and cefuroxime in cataract surgery. Br J Ophthalmol. 1990 Dec;74(12):734–738. doi: 10.1136/bjo.74.12.734. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kowalski R. P., Karenchak L. M., Eller A. W. The role of ciprofloxacin in endophthalmitis therapy. Am J Ophthalmol. 1993 Dec 15;116(6):695–699. doi: 10.1016/s0002-9394(14)73468-3. [DOI] [PubMed] [Google Scholar]
  11. LEOPOLD I. H., APT L. Postoperative intraocular infections. Am J Ophthalmol. 1960 Dec;50:1225–1247. doi: 10.1016/0002-9394(60)91013-8. [DOI] [PubMed] [Google Scholar]
  12. Meredith T. A. Prevention of postoperative infection. Arch Ophthalmol. 1991 Jul;109(7):944–945. doi: 10.1001/archopht.1991.01080070056034. [DOI] [PubMed] [Google Scholar]
  13. Parkkari M., Päivärinta H., Salminen L. The treatment of endophthalmitis after cataract surgery: review of 26 cases. J Ocul Pharmacol Ther. 1995 Fall;11(3):349–359. doi: 10.1089/jop.1995.11.349. [DOI] [PubMed] [Google Scholar]
  14. Pflugfelder S. C., Hernández E., Fliesler S. J., Alvarez J., Pflugfelder M. E., Forster R. K. Intravitreal vancomycin. Retinal toxicity, clearance, and interaction with gentamicin. Arch Ophthalmol. 1987 Jun;105(6):831–837. doi: 10.1001/archopht.1987.01060060117045. [DOI] [PubMed] [Google Scholar]
  15. Puliafito C. A., Baker A. S., Haaf J., Foster C. S. Infectious endophthalmitis. Review of 36 cases. Ophthalmology. 1982 Aug;89(8):921–929. [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES